Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Research

Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study

Mahyar Etminan, Farzin Forooghian and David Maberley
CMAJ May 15, 2012 184 (8) E431-E434; DOI: https://doi.org/10.1503/cmaj.111752
Mahyar Etminan
From the Therapeutic Evaluation Unit (Etminan), Pharmaceutical Outcomes Programme, the Child and Family Research Institute, Vancouver, BC; and the Departments of Medicine (Etminan) and Ophthalmology & Visual Sciences (Forooghian, Maberly), University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: metminan@popi.ubc.ca
Farzin Forooghian
From the Therapeutic Evaluation Unit (Etminan), Pharmaceutical Outcomes Programme, the Child and Family Research Institute, Vancouver, BC; and the Departments of Medicine (Etminan) and Ophthalmology & Visual Sciences (Forooghian, Maberly), University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Maberley
From the Therapeutic Evaluation Unit (Etminan), Pharmaceutical Outcomes Programme, the Child and Family Research Institute, Vancouver, BC; and the Departments of Medicine (Etminan) and Ophthalmology & Visual Sciences (Forooghian, Maberly), University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 184 no. 8 E431-E434
DOI 
https://doi.org/10.1503/cmaj.111752
PubMed 
22470169
History 
  • Published online May 14, 2012.

Article Versions

  • Latest version (April 2, 2012 - 08:20).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2012 Canadian Medical Association or its licensors

Author Information

  1. Mahyar Etminan, PharmD MSc⇑,
  2. Farzin Forooghian, MD MSc,
  3. David Maberley, MD MSc
  1. From the Therapeutic Evaluation Unit (Etminan), Pharmaceutical Outcomes Programme, the Child and Family Research Institute, Vancouver, BC; and the Departments of Medicine (Etminan) and Ophthalmology & Visual Sciences (Forooghian, Maberly), University of British Columbia, Vancouver, BC
  1. Correspondence to:
    Mahyar Etminan, metminan{at}popi.ubc.ca
View Full Text

Statistics from Altmetric.com

Usage statistics: April 2012 to June 2023

AbstractFullPdf
Apr 20121538192390
May 20121564230410
Jun 201290086190
Jul 2012373101105
Aug 20122136089
Sep 20122264797
Oct 20121692558
Nov 20121513453
Dec 20121082246
Jan 20131294139
Feb 2013992246
Mar 20131442545
Apr 20131792631
May 20131062046
Jun 201362717
Jul 201356513
Aug 2013731732
Sep 201369419
Oct 2013841320
Nov 201360820
Dec 201345617
Jan 201464817
Feb 201444528
Mar 201444113
Apr 201450213
May 201448514
Jun 2014812226
Jul 201431511
Aug 201444817
Sep 2014601719
Oct 2014421415
Nov 201443619
Dec 201460518
Jan 2015631116
Feb 201540813
Mar 201549146
Apr 201515715
May 201528412
Jun 20152728
Jul 201538314
Aug 201534615
Sep 201512614
Oct 201526414
Nov 201526610
Dec 2015381113
Jan 20163526420
Feb 2016222119
Mar 20161711823
Apr 20161712321
May 20161416221
Jun 20162112818
Jul 20163225312
Aug 20163811615
Sep 201646259
Oct 2016272117
Nov 2016483228
Dec 2016222813
Jan 2017222917
Feb 2017203314
Mar 2017313014
Apr 2017393618
May 2017291819
Jun 2017231720
Jul 2017352924
Aug 2017291316
Sep 2017282919
Oct 2017252414
Nov 2017294214
Dec 201713252
Jan 20182411710
Feb 2018603014
Mar 2018452727
Apr 2018304418
May 2018365516
Jun 2018366517
Jul 2018334513
Aug 201815267
Sep 2018203412
Oct 2018274511
Nov 2018116613
Dec 20182595
Jan 201954510
Feb 20196327
Mar 201962211
Apr 2019131514
May 2019786
Jun 201981119
Jul 201961214
Aug 20192129
Sep 20198218
Oct 20194174
Nov 2019112111
Dec 20198286
Jan 2020173911
Feb 20208227
Mar 20207205
Apr 20202139
May 20201551
Jun 2020111713
Jul 202017275
Aug 20205156
Sep 2020121211
Oct 2020142116
Nov 20205227
Dec 2020152112
Jan 202181413
Feb 202121910
Mar 2021144218
Apr 2021103817
May 2021152510
Jun 2021103216
Jul 202162119
Aug 20219910
Sep 202183424
Oct 2021143729
Nov 202151924
Dec 20214216
Jan 2022102416
Feb 20226165
Mar 2022123114
Apr 20229217
May 202233065
Jun 2022123028
Jul 202281415
Aug 202243222
Sep 2022102918
Oct 202252432
Nov 202272110
Dec 202272111
Jan 20230248
Feb 20235168
Mar 2023187
Apr 202321616
May 20236198
Jun 2023100

Cited By...

  • 36 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 184 (8)
CMAJ
Vol. 184, Issue 8
15 May 2012
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
Mahyar Etminan, Farzin Forooghian, David Maberley
CMAJ May 2012, 184 (8) E431-E434; DOI: 10.1503/cmaj.111752

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
Mahyar Etminan, Farzin Forooghian, David Maberley
CMAJ May 2012, 184 (8) E431-E434; DOI: 10.1503/cmaj.111752
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Interpretation
    • Footnotes
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjogren Syndrome: A General Population-based Study
  • Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) from British Columbia, Canada
  • Pro-inflammatory and anti-angiogenic effects of bisphosphonates on human cultured retinal pigment epithelial cells
  • New Bisphosphonate Use Associated with Uveitis and Scleritis
  • Google Scholar

More in this TOC Section

  • Statin initiation and risk of incident kidney disease in patients with diabetes
  • Acute care related to cannabis use during pregnancy after the legalization of nonmedical cannabis in Ontario
  • Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
Show more Research

Similar Articles

Collections

  • Topics
    • Drugs: adverse reactions
    • Ophthalmology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire